Superworth

Gossamer Bio profit margin GOSS

Gross, operating and net profit as a share of revenue over the last twelve months, from 2024.

Net margin, 12 months
n/m
not a meaningful number
Peer median
11.6%

Gossamer Bio's net margin works out at −235% over the last twelve months, but it is not a meaningful number: a margin outside minus 100% to 100% is moved by items that are not sales.

Profit margin over time

OperatingNet

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearNet marginOperating margin
FY2025n/an/a
FY2024−49.3%−52.2%
FY2023n/an/a
FY2022n/an/a
FY2021n/an/a
FY2020n/an/a
FY2019n/an/a
FY2018n/an/a

Quarter by quarter

QuarterEndedNet margin, 12 monthsChange on a yearOperating margin
Q2 FY26n/an/an/a
Q1 FY26n/an/an/a
Q4 FY25n/an/an/a
Q3 FY25n/an/an/a
Q2 FY25n/an/an/a
Q1 FY25−41.1%n/a−44.0%
Q4 FY24−49.3%n/a−52.2%
Q3 FY24−68.0%n/a−69.1%
Q2 FY24−84.4%n/a−82.8%
Q1 FY24n/an/an/a
Q4 FY23n/an/an/a
Q3 FY23n/an/an/a

Against its peers

Companies in Drug Manufacturers - General nearest Gossamer Bio's size, closest first, today.

CompanyProfit margin
GOSSGossamer Bion/m
SPROSpero Therapeutics15.7%
ATNMActinium Pharmaceuticalsn/m
LFVNLifevantage2.8%
NATRNatures Sunshine Products3.7%
ARVNArvinas2.9%
PBYIPuma Biotechnology11.6%
IRWDIronwood Pharmaceuticals33.4%
ZVRAZevra Therapeutics42.8%
Peer median11.6%

What the profit margin tells you

Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).

Compare within an industry. 10% is superb for a retailer and poor for a software company.

More on Gossamer Bio

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.